| Discovery, development, and patent trends on molnupiravir: a prospective oral treatment for COVID-19 M Imran, M Kumar Arora, SMB Asdaq, SA Khan, SI Alaqel, ... Molecules 26 (19), 5795, 2021 | 184 | 2021 |
| Biological activities of sulfonamides MA Bhat, M Imran, SA Khan, N Siddiqui Indian journal of pharmaceutical sciences 67 (2), 151-159, 2005 | 73 | 2005 |
| Novel quinazoline-based EGFR kinase inhibitors: A review focussing on SAR and molecular docking studies (2015-2019) P Bhatia, V Sharma, O Alam, A Manaithiya, P Alam, MT Alam, M Imran European Journal of Medicinal Chemistry 204, 112640, 2020 | 64 | 2020 |
| Synthesis, characterization, and DFT modeling of novel organic compound thin films derived from 2-amino-4-(2-hydroxy-3-methoxyphenyl)-4H-thiazolo [3, 2-a][1, 3, 5] triazin-6 … HK Thabet, AF Al-Hossainy, M Imran Optical Materials 105, 109915, 2020 | 59 | 2020 |
| An updated review: newer quinazoline derivatives under clinical trial. P Nayyar, R Arpana, I Mohd International journal of pharmaceutical and biological archives 2 (6), 1651-1657, 2011 | 59* | 2011 |
| Ultrasound-assisted extraction of some branded tea: Optimization based on polyphenol content, antioxidant potential and thermodynamic study MA Bakht, MH Geesi, Y Riadi, M Imran, MI Ali, MJ Ahsan, N Ajmal Saudi journal of biological sciences 26 (5), 1043-1052, 2019 | 58 | 2019 |
| Thiazole: A versatile standalone moiety contributing to the development of various drugs and biologically active agents MF Arshad, A Alam, AA Alshammari, MB Alhazza, IM Alzimam, MA Alam, ... Molecules 27 (13), 3994, 2022 | 56 | 2022 |
| Innovations and development of COVID-19 vaccines: A patent review AS Alshrari, SA Hudu, M Imran, SMB Asdaq, AM Ali, SI Rabbani Journal of infection and public health 15 (1), 123-131, 2022 | 45 | 2022 |
| The therapeutic and prophylactic potential of quercetin against COVID-19: An outlook on the clinical studies, inventive compositions, and patent literature M Imran, HK Thabet, SI Alaqel, AR Alzahrani, A Abida, MK Alshammari, ... Antioxidants 11 (5), 876, 2022 | 42 | 2022 |
| Experimental and computational approaches for solubility measurement of pyridazinone derivative in binary (DMSO+ water) systems F Shakeel, S Alshehri, M Imran, N Haq, A Alanazi, MK Anwer Molecules 25 (1), 171, 2020 | 42 | 2020 |
| Solubility and thermodynamic/solvation behavior of 6-phenyl-4, 5-dihydropyridazin-3 (2H)-one in different (Transcutol+ water) mixtures F Shakeel, M Imran, N Haq, FK Alanazi, IA Alsarra Journal of Molecular Liquids 230, 511-517, 2017 | 40 | 2017 |
| Synthetic molecules as DprE1 inhibitors: A patent review M Imran, A AS, HK Thabet, Abida, M Afroz Bakht Expert Opinion on Therapeutic Patents 31 (8), 759-772, 2021 | 33 | 2021 |
| Innovations and patent trends in the development of USFDA approved protein kinase inhibitors in the last two decades M Imran, SMB Asdaq, SA Khan, D Unnikrishnan Meenakshi, AS Alamri, ... Pharmaceuticals 14 (8), 710, 2021 | 32 | 2021 |
| Trends in the development of remdesivir based inventions against COVID-19 and other disorders: A patent review M Imran, AS Alshrari, SMB Asdaq Journal of Infection and Public Health 14 (8), 1075-1086, 2021 | 30 | 2021 |
| Synthesis and antimicrobial activity of some novel quinoline-pyrazoline-based coumarinyl thiazole derivatives MI Ansari, SA Khan Medicinal Chemistry Research 26, 1481-1496, 2017 | 30 | 2017 |
| A Review on the Main Phytoconstituents, Traditional Uses, Inventions, and Patent Literature of Gum Arabic Emphasizing Acacia seyal MA Ashour, W Fatima, M Imran, MM Ghoneim, S Alshehri, F Shakeel Molecules 27 (4), 1171, 2022 | 29 | 2022 |
| Synthesis, characterization and anticoagulant activity of chitosan derivatives M Imran, M Sajwan, B Alsuwayt, M Asif Saudi pharmaceutical journal 28 (1), 25-32, 2020 | 29 | 2020 |
| Knowledge, attitude and practices of healthcare professionals of riyadh, saudi arabia towards covid-19: a cross-sectional study SMB Asdaq, AS Alshrari, M Imran, N Sreeharsha, R Sultana Saudi Journal of Biological Sciences 28 (9), 5275-5282, 2021 | 28 | 2021 |
| A glance at the development and patent literature of tecovirimat: The first-in-class therapy for emerging monkeypox outbreak M Almehmadi, M Allahyani, AA Alsaiari, MK Alshammari, AS Alharbi, ... Viruses 14 (9), 1870, 2022 | 27 | 2022 |
| Recent thiazolidinediones as antidiabetics M Imran, B Ilyas, SA Khan CSIR, 2007 | 26 | 2007 |
Dr AbidaNorthern Border University, Rafha,Saudi ArabiaVerified email at nbu.edu.sa
